As the HIV prevention field continues to evolve, appropriately evaluating the potential advantages of MPT products becomes more complicated, and opportunities for the progression of MPTs through full development to commercialization may be limited. The Clinical Trial Evaluation Workshop for MPTs brought together MPT stakeholders with the goal of informing an overall strategy for the successful clinical evaluation of MPTs. Participants outlined strategies for successfully addressing challenges and risks, and identified critical market issues that can be addressed through clinical evaluations of MPTs, or through the study of intended target populations.

This project is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of Cooperative Agreement #AID-OAA-A-16-00045. The contents are the responsibility of the IMPT, CAMI Health, PHI, and its partners and do not necessarily reflect the views of USAID or the U.S. Government.